In vitro intercalation assays revealed that DOCK4 depleted breast cancer cells display a significant delay in intercalation compared to control cells (Fig. 2c, d and Supplementary Movie 2); whereas adhesion assays performed in parallel showed that cancer cells lacking DOCK4 are as efficient as control cells in adhering to BEC (Fig. 2e). Here, DOCK4 is linked to cancer.